Single-partner platforms promise to replace fragmented prescription hubs with one connected, data-driven journey for manufacturers and patients alike.
Myunghee Song
Advertisement
Myunghee Song is director of ADC Analytical Development at Samsung Biologics.
Articles by Myunghee Song
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Gilead to Buy Oral IL-23R Peptide HCXT-2001 for $1.275 Billion
2
Treasury Proposes Adding Biotech to Outbound Investment Restrictions Under COINS Act
3
Zymeworks Licenses DLL3-Targeted Trispecific T-Cell Engager ZW209 to Roche in Deal Worth Up to $813 Million
4
FDA Approves On-Body Injector Induction for Skyrizi in Crohn's Disease
5